India’s Zydus Cadila plans to complete late-stage trials for its potential coronavirus vaccine in March 2021 and could produce up to 100 million doses a year if trials are successful, Chairman Pankaj Patel told Reuters.

Cadila’s vaccine candidate, dubbed ZyCov-D, is one of dozens being developed around the world to fight the coronavirus.

Source: REUTERS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.